Statin Effects on HDL Cholesterol

Clinical Guidelines and Recommendations

The American Diabetes Association recognizes that raising HDL cholesterol is difficult except with nicotinic acid or fibrates, and statins are not listed as primary HDL-raising agents 1
The American Heart Association/American Stroke Association guidelines note that statins lower LDL cholesterol by 30-50% and reduce stroke risk by approximately 21% 2
Current documentation of risk reduction through HDL-raising therapy alone is not sufficient to warrant setting a specific goal value for raising HDL cholesterol in clinical practice 3

By inhibiting HMG-CoA reductase, statins decrease hepatic cholesterol synthesis and upregulate LDL receptors, which secondarily affects HDL metabolism through reduced CETP activity 4

In patients with combined hyperlipidemia requiring HDL elevation, consider adding fibrates or nicotinic acid rather than relying on statins alone, with fenofibrate preferred over gemfibrozil when combined with statins due to lower myopathy risk 1